List of Ra Pharmaceuticals patents

Patents where

Current Assignee

Name

Ra Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10588936 Modulators of complement activity	Patent 10588936 was granted and assigned to Ra Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10588936	March 17, 2020
‌ US Patent 10106579 Modulation of complement activity	Patent 10106579 was granted and assigned to Ra Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10106579	October 23, 2018
‌ US Patent 10208089 Modulation of complement activity	Patent 10208089 was granted and assigned to Ra Pharmaceuticals on February, 2019 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10208089	February 19, 2019
‌ US Patent 10435438 Modulation of complement activity	Patent 10435438 was granted and assigned to Ra Pharmaceuticals on October, 2019 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10435438	October 8, 2019
‌ US Patent 11123399 Modulators of complement activity	Patent 11123399 was granted and assigned to Ra Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	11123399	September 21, 2021
‌ US Patent 10954287 Ras binding peptides and methods of use	Patent 10954287 was granted and assigned to Ra Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10954287	March 23, 2021
‌ US Patent 10328115 Modulators of complement activity	Patent 10328115 was granted and assigned to Ra Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10328115	June 25, 2019
‌ US Patent 9644004 Peptide and peptidomimetic inhibitors	Patent 9644004 was granted and assigned to Ra Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	9644004	May 9, 2017
‌ US Patent 10918691 Modulators of complement activity	Patent 10918691 was granted and assigned to Ra Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10918691	February 16, 2021
‌ US Patent 9937222 Modulators of complement activity	Patent 9937222 was granted and assigned to Ra Pharmaceuticals on April, 2018 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	9937222	April 10, 2018
‌ US Patent 11535650 Modulation of complement activity		Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	11535650	December 27, 2022
‌ US Patent 11014965 Modulation of complement activity	Patent 11014965 was granted and assigned to Ra Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	11014965	May 25, 2021
‌ US Patent 10835574 Modulators of complement activity	Patent 10835574 was granted and assigned to Ra Pharmaceuticals on November, 2020 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10835574	November 17, 2020
‌ US Patent 9238676 Peptide and peptidomimetic inhibitors	Patent 9238676 was granted and assigned to Ra Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	9238676	January 19, 2016
‌ US Patent 10272132 Peptide and peptidomimetic inhibitors	Patent 10272132 was granted and assigned to Ra Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10272132	April 30, 2019
‌ US Patent 9999650 Peptide and peptidomimetic inhibitors	Patent 9999650 was granted and assigned to Ra Pharmaceuticals on June, 2018 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	9999650	June 19, 2018
‌ US Patent 10562934 Modulation of complement activity	Patent 10562934 was granted and assigned to Ra Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	10562934	February 18, 2020
‌ US Patent 11752190 Modulators of complement activity	Patent 11752190 was granted and assigned to Ra Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	11752190	September 12, 2023
‌ US Patent 11965040 Modulation of complement activity	Patent 11965040 was granted and assigned to Ra Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.	Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	11965040	April 23, 2024
‌ US Patent 11707503 Modulators of complement activity		Ra Pharmaceuticals	Ra Pharmaceuticals	United States Patent and Trademark Office	11707503	July 25, 2023

20 results

0 selected

20 results

0 selected